Latest News

QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

VENLO, Netherlands–(BUSINESS WIRE)–QIAGEN N.V. announces that it will initiate the repurchase of a fourth tranche of shares under the share repurchase program which was announced by an ad hoc announcement dated January 31, 2018. In the time period between May 10, 2019 until June 18, 2019, at the latest, a fourth tranche of up to 2 million common shares of the Company having a total purchase price of up to USD 50┬ámillion (or the equivalent Euro amount thereof, in each case without ancillary pu

Source link

Related posts

Antiepileptic drugs linked to increased hospital stays in persons with Alzheimer's disease


Genetics determine whether you are an early riser or a night owl


OneDigital Delivers Cutting-Edge COVID-19 Health Plan Cost Impact Tool


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World